Haemoglobin
Measuring Haemoglobin supports clinical assessment of full blood count and can help identify patterns consistent with dysfunction or active disease processes.
Booking product
Advanced GP2 is a private blood test available at Manchester Chemist. It includes 86 biomarkers, processed by Randox, an expected turnaround time of 72hrs, test code HSC8F/M, and prices from ยฃ190.This panel is designed t...
Advanced GP2 is a private blood test available at Manchester Chemist. It includes 86 biomarkers, processed by Randox, an expected turnaround time of 72hrs, test code HSC8F/M, and prices from ยฃ190.
This panel is designed to support assessment of bone health, diabetes, full blood count, heart health, infection & inflammation, iron status, kidney health, liver health, metabolic syndrome, muscle & joint health, nutritional health, stress health, thyroid health, tumour markers, and urine analysis. It may be useful for screening, monitoring, or investigating health concerns in the appropriate clinical context.
Samples are taken on site by our trained team. If you are unsure whether this is the right test for you, please contact Manchester Chemist before booking.
| Advanced GP2 |
| Health Screens |
| Retail Price: ยฃ190.00 |
| Provider: Randox |
| Test Code: HSC8F/M |
| Turn Around Time: 72hrs |
| Total Biomarkers: 86 |
| Full Blood Count |
| Haemoglobin |
| Hematocrit |
| Mean Cell Haemoglobin |
| Mean Cell Haemoglobin Concentration (MCHC) |
| Mean Cell Volume |
| Red Blood Cell Count |
| Basophil Count |
| Lymphocyte Count |
| Eosinophil Count |
| Monocyte Count |
| Neutrophil Count |
| White Blood Cell Count |
| Platelet Count |
| Heart Health |
| Total Cholesterol |
| LDL Cholesterol |
| HDL Cholesterol |
| Total Cholesterol/HDL Cholesterol Ratio |
| Triglycerides |
| High Sensitivity C-Reactive Protein |
| Apolipoprotein A-I |
| Apolipoprotein B |
| Apolipoprotein B / A-I Ratio |
| Apolipoprotein CII |
| Apolipoprotein CIII |
| Apolipoprotein E |
| Cardiovascular Risk Score |
| Lipoprotein (a) |
| Small LDL Cholesterol |
| Liver Health |
| Alkaline Phosphatase |
| Alanine Aminotransferase |
| Aspartate Transferase |
| Gamma-glutamyl Transferase |
| Total Bilirubin |
| Albumin |
| Kidney Health |
| Creatinine |
| eGFR |
| Chloride |
| Potassium* |
| Phosphate |
| Sodium |
| Urea |
| Cystatin C |
| Magnesium |
| Uric Acid |
| Calcium |
| Bone Health |
| Alkaline Phosphatase |
| Calcium (Adjusted) |
| Phosphate |
| Vitamin D |
| Diabetes |
| Glucose |
| HbA1c |
| Insulin |
| C-Peptide |
| Urine Analysis |
| Bilirubin |
| Glucose |
| Ketones |
| Nitrite |
| pH |
| Protein |
| Red Blood Cells |
| Urobilinogen |
| White Blood Cells |
| Muscle & Joint Health |
| Uric Acid |
| Iron Status |
| Ferritin |
| Iron |
| Total Iron Binding Capacity |
| Transferrin |
| Transferrin Saturation |
| Infection & Inflammation |
| C-Reactive Protein |
| Nutritional Health |
| Vitamin D |
| Calcium (Adjusted) |
| Albumin |
| Iron |
| Magnesium |
| Thyroid Health |
| Thyroid Stimulating Hormone |
| Free Tri-iodothyronine (FT3) |
| Free Thyroxine (FT4) |
| Anti-Thyroglobulin Antibody |
| Anti-Thyroid Peroxidase |
| Antibody |
| Tumour Markers |
| Total Prostate |
| Specific Antigen (M) |
| CA-125 (F) |
| Metabolic Syndrome |
| Leptin |
| Adiponectin |
| Resistin |
Biomarkers used to assess red cells, white cells, platelets, and related haematology patterns.
Measuring Haemoglobin supports clinical assessment of full blood count and can help identify patterns consistent with dysfunction or active disease processes.
Platelet Count is included to evaluate aspects of full blood count, helping interpret function, balance, or potential abnormalities.
White Blood Cell Count contributes to the full blood count profile, offering information that may be useful for screening or monitoring in the appropriate clinical context.
Neutrophil Count provides insight into physiology relevant to full blood count, and is commonly used for screening or follow-up.
Monocyte Count provides insight into physiology relevant to full blood count, and is commonly used for screening or follow-up.
Measuring Eosinophil Count supports clinical assessment of full blood count and can help identify patterns consistent with dysfunction or active disease processes.
Lymphocyte Count provides insight into physiology relevant to full blood count, and is commonly used for screening or follow-up.
Basophil Count provides insight into physiology relevant to full blood count, and is commonly used for screening or follow-up.
Red Blood Cell Count contributes to the full blood count profile, offering information that may be useful for screening or monitoring in the appropriate clinical context.
Mean Cell Volume provides insight into physiology relevant to full blood count, and is commonly used for screening or follow-up.
Measuring Mean Cell Haemoglobin Concentration (MCHC) supports clinical assessment of full blood count and can help identify patterns consistent with dysfunction or active disease processes.
Mean Cell Haemoglobin is included to evaluate aspects of full blood count, helping interpret function, balance, or potential abnormalities.
Hematocrit contributes to the full blood count profile, offering information that may be useful for screening or monitoring in the appropriate clinical context.
Biomarkers used to assess metabolic risk and cardiometabolic balance.
Leptin provides insight into physiology relevant to metabolic syndrome, and is commonly used for screening or follow-up.
Resistin contributes to the metabolic syndrome profile, offering information that may be useful for screening or monitoring in the appropriate clinical context.
Adiponectin provides insight into physiology relevant to metabolic syndrome, and is commonly used for screening or follow-up.
Biomarkers used to support cancer-related assessment in the appropriate clinical context.
Measuring Total Prostate Specific Antigen (M) supports clinical assessment of tumour markers and can help identify patterns consistent with dysfunction or active disease processes.
Measuring CA-125 (F) supports clinical assessment of tumour markers and can help identify patterns consistent with dysfunction or active disease processes.
Biomarkers used to assess thyroid hormone balance and thyroid autoimmunity.
Thyroid Stimulating Hormone provides insight into physiology relevant to thyroid health, and is commonly used for screening or follow-up.
Anti-Thyroid Peroxidase Antibody provides insight into physiology relevant to thyroid health, and is commonly used for screening or follow-up.
Anti-Thyroglobulin Antibody contributes to the thyroid health profile, offering information that may be useful for screening or monitoring in the appropriate clinical context.
Free Thyroxine (FT4) contributes to the thyroid health profile, offering information that may be useful for screening or monitoring in the appropriate clinical context.
Free Tri-iodothyronine (FT3) contributes to the thyroid health profile, offering information that may be useful for screening or monitoring in the appropriate clinical context.
Biomarkers used to assess vitamin, mineral, and broader nutritional status.
Measuring Magnesium supports clinical assessment of nutritional health and can help identify patterns consistent with dysfunction or active disease processes.
Measuring Iron supports clinical assessment of nutritional health and can help identify patterns consistent with dysfunction or active disease processes.
Calcium (Adjusted) contributes to the nutritional health profile, offering information that may be useful for screening or monitoring in the appropriate clinical context.
Measuring Albumin supports clinical assessment of nutritional health and can help identify patterns consistent with dysfunction or active disease processes.
Vitamin D provides insight into physiology relevant to nutritional health, and is commonly used for screening or follow-up.
Biomarkers used to assess inflammatory activity and possible infection.
C-Reactive Protein is included to evaluate aspects of infection & inflammation, helping interpret function, balance, or potential abnormalities.
Biomarkers used to assess iron storage, transport, and iron availability.
Ferritin reflects iron stores and helps assess iron deficiency or iron overload in clinical context.
Transferrin Saturation is included to evaluate aspects of iron status, helping interpret function, balance, or potential abnormalities.
Transferrin contributes to the iron status profile, offering information that may be useful for screening or monitoring in the appropriate clinical context.
Total Iron Binding Capacity provides insight into physiology relevant to iron status, and is commonly used for screening or follow-up.
Iron contributes to the iron status profile, offering information that may be useful for screening or monitoring in the appropriate clinical context.
Biomarkers used to assess muscle injury, inflammation, and joint-related processes.
End-product of purine metabolism; elevated levels are associated with gout, kidney stones, and metabolic risk.
Biomarkers used to assess urinary tract findings and urine chemistry.
Measuring Bilirubin supports clinical assessment of urine analysis and can help identify patterns consistent with dysfunction or active disease processes.
Measuring White Blood Cells supports clinical assessment of urine analysis and can help identify patterns consistent with dysfunction or active disease processes.
Urobilinogen is included to evaluate aspects of urine analysis, helping interpret function, balance, or potential abnormalities.
Measuring Red Blood Cells supports clinical assessment of urine analysis and can help identify patterns consistent with dysfunction or active disease processes.
Protein contributes to the urine analysis profile, offering information that may be useful for screening or monitoring in the appropriate clinical context.
Measuring pH supports clinical assessment of urine analysis and can help identify patterns consistent with dysfunction or active disease processes.
Nitrite is included to evaluate aspects of urine analysis, helping interpret function, balance, or potential abnormalities.
Ketones contributes to the urine analysis profile, offering information that may be useful for screening or monitoring in the appropriate clinical context.
Glucose provides insight into physiology relevant to urine analysis, and is commonly used for screening or follow-up.
Biomarkers used to assess bone turnover and mineral status.
Measuring Alkaline Phosphatase supports clinical assessment of bone health and can help identify patterns consistent with dysfunction or active disease processes.
Vitamin D contributes to the bone health profile, offering information that may be useful for screening or monitoring in the appropriate clinical context.
Phosphate contributes to the bone health profile, offering information that may be useful for screening or monitoring in the appropriate clinical context.
Calcium (Adjusted) provides insight into physiology relevant to bone health, and is commonly used for screening or follow-up.
Biomarkers used to assess glucose regulation and diabetes risk or control.
Measuring Glucose supports clinical assessment of diabetes and can help identify patterns consistent with dysfunction or active disease processes.
C-Peptide is included to evaluate aspects of diabetes, helping interpret function, balance, or potential abnormalities.
Measuring Insulin supports clinical assessment of diabetes and can help identify patterns consistent with dysfunction or active disease processes.
HbA1c reflects average blood glucose over about 2-3 months and is used for diabetes screening and monitoring.
Biomarkers used to assess renal filtration, electrolyte balance, and kidney function.
Creatinine is a waste product filtered by the kidneys and is used to estimate kidney filtration (eGFR).
Calcium is included to evaluate aspects of kidney health, helping interpret function, balance, or potential abnormalities.
End-product of purine metabolism; elevated levels are associated with gout, kidney stones, and metabolic risk.
Magnesium is included to evaluate aspects of kidney health, helping interpret function, balance, or potential abnormalities.
Cystatin C contributes to the kidney health profile, offering information that may be useful for screening or monitoring in the appropriate clinical context.
Measuring Urea supports clinical assessment of kidney health and can help identify patterns consistent with dysfunction or active disease processes.
Measuring Sodium supports clinical assessment of kidney health and can help identify patterns consistent with dysfunction or active disease processes.
Phosphate contributes to the kidney health profile, offering information that may be useful for screening or monitoring in the appropriate clinical context.
Measuring Potassium* supports clinical assessment of kidney health and can help identify patterns consistent with dysfunction or active disease processes.
Chloride is included to evaluate aspects of kidney health, helping interpret function, balance, or potential abnormalities.
Estimated glomerular filtration rate is calculated from creatinine and helps describe kidney filtration performance.
Biomarkers used to assess hepatic function, liver cell integrity, and biliary activity.
Measuring Alkaline Phosphatase supports clinical assessment of liver health and can help identify patterns consistent with dysfunction or active disease processes.
Albumin contributes to the liver health profile, offering information that may be useful for screening or monitoring in the appropriate clinical context.
Total Bilirubin contributes to the liver health profile, offering information that may be useful for screening or monitoring in the appropriate clinical context.
Measuring Gamma-glutamyl Transferase supports clinical assessment of liver health and can help identify patterns consistent with dysfunction or active disease processes.
Measuring Aspartate Transferase supports clinical assessment of liver health and can help identify patterns consistent with dysfunction or active disease processes.
Alanine Aminotransferase is included to evaluate aspects of liver health, helping interpret function, balance, or potential abnormalities.
Biomarkers used to assess lipid balance and cardiovascular risk.
Total Cholesterol is included to evaluate aspects of heart health, helping interpret function, balance, or potential abnormalities.
Measuring Small LDL Cholesterol supports clinical assessment of heart health and can help identify patterns consistent with dysfunction or active disease processes.
Lipoprotein (a) provides insight into physiology relevant to heart health, and is commonly used for screening or follow-up.
Cardiovascular Risk Score contributes to the heart health profile, offering information that may be useful for screening or monitoring in the appropriate clinical context.
Apolipoprotein E contributes to the heart health profile, offering information that may be useful for screening or monitoring in the appropriate clinical context.
Apolipoprotein CIII provides insight into physiology relevant to heart health, and is commonly used for screening or follow-up.
Apolipoprotein CII is included to evaluate aspects of heart health, helping interpret function, balance, or potential abnormalities.
Apolipoprotein B / A-I Ratio contributes to the heart health profile, offering information that may be useful for screening or monitoring in the appropriate clinical context.
Measuring Apolipoprotein B supports clinical assessment of heart health and can help identify patterns consistent with dysfunction or active disease processes.
Apolipoprotein A-I contributes to the heart health profile, offering information that may be useful for screening or monitoring in the appropriate clinical context.
Measuring High Sensitivity C-Reactive Protein supports clinical assessment of heart health and can help identify patterns consistent with dysfunction or active disease processes.
Triglycerides contributes to the heart health profile, offering information that may be useful for screening or monitoring in the appropriate clinical context.
Total Cholesterol/HDL Cholesterol Ratio contributes to the heart health profile, offering information that may be useful for screening or monitoring in the appropriate clinical context.
HDL Cholesterol is included to evaluate aspects of heart health, helping interpret function, balance, or potential abnormalities.
LDL Cholesterol is included to evaluate aspects of heart health, helping interpret function, balance, or potential abnormalities.